Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
filingDate |
2000-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b227c070d630113e2ac81f328e320f5 |
publicationDate |
2003-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6593097-B1 |
titleOfInvention |
Reverse-phase HPLC assay for plasminogen activators |
abstract |
A process is described for monitoring the effectiveness of a purification process in removing plasminogen activator (PA) endogenous to Chinese hamster ovary (CHO) cells from a sample containing human tPA or variants thereof. This process comprises incubating the sample with a protease capable of specifically cleaving the Arg275-Ile276 bond of human wild-type tPA and then with denaturing/reducing agents in respective amounts effective to reduce the disulfide bonds of human wild-type tPA; subjecting the sample to a reversed-phase high-performance liquid chromatography step, and analyzing the elution profile from the chromatography step for the amount of PA endogenous to the CHO cells present therein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2210948-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8350013-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7714111-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018162612-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2105496-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1978098-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008064860-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008064861-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6972327-B1 |
priorityDate |
1999-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |